http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-052657-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
filingDate 2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69f32d2fa709c3c7939390217fb4204a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd20afaa85c8284db8c30cea00698a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60448e633af50c8ca2153225a57b2e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac226fda2c73beb9fdb0009f82aa410d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d65f5a23ca1c30b78f890ba27e25d15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a277e55f8bfef397c7407e8147c304f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4cd78529ecc7f61d8bdc940fcf2d8dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07e086a465f119d58018eed17e4a357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d10c30e36a9796d5c224b24b0912ba
publicationDate 2007-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-052657-A1
titleOfInvention 18-METIL-19-NOR-17-PREGN-4-EN-21,17-CARBOLACTONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract 18-methyl-19-nor-17-pregn-4-en-21.17-carbolactones of the general formula (1) wherein Z is an O atom, two H atoms, a group = NOR or = NNHSO2R, wherein R is an H atom or a C1-4 or C3-4 straight or branched chain alkyl group; R4 is an atom of H, halogen, methyl or trifluoromethyl; R6 and / or R7 may be in alpha or beta position and are, independently of each other, C1-3 or C3-4 straight or branched chain alkyl, or R6 is an atom of H and R7 is a chain alkyl group linear or branched in alpha or beta position with C1-4 or C3-4 or R6 and R7 are each an atom of H or R6 and R7 together form a methylene group in alpha or beta position or an additional bond. These compounds have a gestagenic and antimineralocorticoid action and are suitable for producing pharmaceutical preparations, for example for oral contraception and the treatment of pre-, peri- and postmenopausal disorders.
priorityDate 2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688

Total number of triples: 31.